Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors
Preoperative Chemo Doubles Survival In Locally Advanced Bladder Cancer
Gleevec Approval Sets Record For FDA Review: 73 Days
Advances Found In Treatment Of Aerodigestive Cancers
Silicone Implants Not Linked To Increased Risk Of Death
B-14 Trial: No Advantage To 10 Years Of Tamoxifen
NCI-Approved Clinical Trials Listed For April 2001
Trending Stories
- Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
Her endowed award will live on - Kevan Shokat made KRAS druggable. With daraxonrasib now in the clinic, he is “all in” on the ultimate target: p53
Shokat was named 2026 Stephenson Global Prize winner - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Iowa’s “cancer crisis” emerges as a top issue on the campaign trail
- California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma









